Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD

Interleukin-33 (IL-33) and thymic stromal lymphopoietin (TSLP) are alarmins that are released upon airway epithelial injury from insults such as viruses and cigarette smoke, and play critical roles in the activation of immune cell populations such as mast cells, eosinophils and group 2 innate lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Calderon, Ariel A., Dimond, Colin, Choy, David F., Pappu, Rajita, Grimbaldeston, Michele A., Mohan, Divya, Chung, Kian Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879340/
https://www.ncbi.nlm.nih.gov/pubmed/36697211
http://dx.doi.org/10.1183/16000617.0144-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879340/
https://www.ncbi.nlm.nih.gov/pubmed/36697211
http://dx.doi.org/10.1183/16000617.0144-2022

Ejemplares similares